for the bio-sciences sector
From 22nd to 23rd September, we attended The Sydney Cancer Conference, a meeting for cancer researchers and all those in related research areas.
For the first time, this conference was co-hosted by six major New South Wales Universities: The University of Sydney, the University of New South Wales, Macquarie University, University of Wollongong, University of Newcastle and the University of Western Sydney.
The conference, held at The Australian Technology Park in the beautifully restored Eveleigh Railway Yards, gave Oxford Optronix the opportunity to meet with many familiar faces, to introduce new developments with our GelCount and OxyLite instruments, and to launch the HypoxyLab hypoxia workstation in Australia.
The meeting was a great success, with more than 400 attendees representing a dynamic and intensive area of scientific reproach in Australia.
Oxford Optronix was represented at the conference by our Sales Manager, Petra Mayr, and by our Business Development Principle, John Coyle.
Petra followed the meeting with a round of highly informative support visits to some of our key customers in Australia, including at Monash University in Melbourne, at The University of Melbourne and at Charles Sturt University in Wagga Wagga.
Australia has been a particularly strong market for our OxyLite™ and OxyFlo™ brands of tissue vitality monitors, with various teams at the forefront of research areas such as renal oxygenation and kidney failure, haemorrhagic shock and resuscitation.
Find out more:
Reflecting on 2016; looking forward to 2017
A little time Down Under…
Latest GelCount software update
Asia distributor workshop
Performance updates for HypoxyLab
Meet us at Genes & Cancer UK, Cambridge
Looking forward to a busy 2015
Oxford Optronix reaches new customers
Strategic tie-up with SciPro Inc., USA
Single-channel OxyFlo™ now shipping
GelCount™ software update
Reflections on 2013
Autumn conference round-up
Our 2013 Customer Survey results are out
Next-generation OxyLite™ and OxyFlo™ monitors